# erythromycin

NDC: 45802-038
Generic name: erythromycin
Labeler / Manufacturer: Padagis Israel Pharmaceuticals Ltd
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: TOPICAL
Marketing started: 20111219

FDA application: ANDA063038

## Active ingredients

- ERYTHROMYCIN: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"45802-038"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=45802-038
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=40edf1bd-42bb-4662-aff6-01fcc133c05d